(Q51477511)

5 April 2018

editorial

0 references

title

Prognosis and prediction in a Facebook world. (English)

1 reference

5 April 2018

0 references

Walter M Stadler

1

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 December 2009

1 reference

5 April 2018

published in

Cancer

1 reference

5 April 2018

volume

115

1 reference

5 April 2018

issue

23

1 reference

5 April 2018

page(s)

5368-5370

1 reference

5 April 2018

Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

Predicting survival after radical cystectomy for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

The 2004 WHO classification of bladder tumors: a summary and commentary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24593

7 January 2021

Identifiers

DOI

10.1002/CNCR.24593

1 reference

5 April 2018

1 reference

5 April 2018